TECH OFFER

A Method Of Preparing An Inactivated Antibiotic-Exposed Whole Acinetobacter Baumannii Vaccine

TECHNOLOGY OVERVIEW

A method of producing a vaccine against multi-drug resistant (MDR) Acinetobacter baumannii comprises the step of isolating a whole cell material of inactivated antibiotic-exposed A. baumannii cultured in presence of an antibiotic at early logarithmic (log) phase of bacterial growth, inactivating the bacteria with chemical and heat at late log phase of bacterial growth and mixing the isolated whole cell material with a preservative. The antibiotic in the culture medium is at an effective concentration hindering the growth of the A. baumannii without substantially killing the A. baumannii and enhances expression of A. baumannii proteins conferring resistance to the antibiotics and virulence. Preferably, imipenem is used.

Mega - Trends

vaccine testing, Chemicals and Materials

Technology Readiness Level (TRL)

TRL 3

Patent Number

MY-168631-A

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

MAKE AN ENQUIRY

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151